Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
The purpose of the study is to review the following points during use of Forxiga Tablets (hereinafter referred to as Forxiga) in the real world setting after launch for treatment of CKD.
1. ADRs which are unexpected from the precautions for use in our JPI
2. Understanding of incidence of ADRs during use of Forxiga in the real world setting
3. Factors (ie demography, treatment) possibly having an impact on the safety.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with CKD except for dialysis and/or renal failure chronic
You may not be if
None
Clareo Health | Forxiga CKD Japan Post-Marketing Surveillance (PMS)
